NICE confirms Xarelto advice
This article was originally published in Scrip
Executive Summary
Bayer's oral anticoagulant Xarelto (rivaroxaban) can be used in the national health service in England and Wales to prevent venous thromboembolism in adults having elective total hip replacement surgery or elective total knee replacement surgery, the National Institute for health and Clinical Excellence has confirmed.